Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
Clinical trial NCT01498419 · COMPLETED
Trial details
- NCT number
- NCT01498419
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-04-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.